Wilmot Cancer Institute to Make Major Announcement on the Future of Cancer Care and Research
Leaders from the Wilmot Cancer Institute, University of Rochester, and University of Rochester Medical Center will make a significant announcement that will shape the future of cancer care and research in Rochester and beyond. This milestone will have a lasting impact on patients, families, researchers, and medical professionals, while also enhancing the national profile of Wilmot and the University. Please join us for a press conference on Wednesday, March 19 at 10:00am. Tune in to the livestream at https://events.rochester.edu/live.
The Director of the Wilmot Cancer Institute, Jonathan Friedberg, MD, MMSc, will be joined by University President Sarah Mangelsdorf and URMC CEO David Linehan, MD to make this announcement which will bring transformative benefits to our patients and their families, as well as the faculty, researchers, providers, and staff at Wilmot and the Medical Center. Its impact will extend beyond Rochester, influencing cancer treatment and research across New York State and beyond.